Biosynex SA (ALBIO) Stock Statistics & Valuation Metrics

Biosynex SA has a market cap or net worth of €16.37M. The enterprise value is €70.41M.

Biosynex SA has 18,748,032 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biosynex SA’s return on equity (ROE) is -1.79 and return on invested capital (ROIC) is -4.09%.

The current PE Ratio of Biosynex SA is ―. Biosynex SA’s PEG ratio is 0.03.

In the last 12 months, Biosynex SA had revenue of 95.20M and earned -58.20M in profits. Earnings per share was -3.10.

In the last 12 months, operating cash flow was -5.89M and capital expenditures -2.69M, giving a free cash flow of -8.57M billion.

Biosynex SA pays an annual dividend of €2, resulting in a dividend yield of ―

Biosynex SA upcoming earnings date is ―, ―.

Biosynex SA as a current ratio of 1.94, with Debt / Equity ratio of 190.01%

In the past 12 months, Biosynex SA has paid -1.10M in taxes.

Biosynex SA EV to EBITDA ratio is 7.57, with an EV/FCF ratio of -7.51.

Biosynex SA has €8.46M in cash and marketable securities with €61.65M in debt, giving a net cash position of -€53.19M billion.

Gross margin is -3.78%, with operating margin of -4.94%, and net profit margin of -61.13%.

The average price target for Biosynex SA is ―, which is 11.43% higher than the current price. The consensus rating is ―